-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Here's Why Option Care Health (NASDAQ:OPCH) Has Caught The Eye Of Investors
Here's Why Option Care Health (NASDAQ:OPCH) Has Caught The Eye Of Investors
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to investors, even if it currently lacks a track record of revenue and profit. But the reality is that when a company loses money each year, for long enough, its investors will usually take their share of those losses. Loss making companies can act like a sponge for capital - so investors should be cautious that they're not throwing good money after bad.
Despite being in the age of tech-stock blue-sky investing, many investors still adopt a more traditional strategy; buying shares in profitable companies like Option Care Health (NASDAQ:OPCH). While profit isn't the sole metric that should be considered when investing, it's worth recognising businesses that can consistently produce it.
See our latest analysis for Option Care Health
Option Care Health's Improving Profits
Strong earnings per share (EPS) results are an indicator of a company achieving solid profits, which investors look upon favourably and so the share price tends to reflect great EPS performance. Which is why EPS growth is looked upon so favourably. It is awe-striking that Option Care Health's EPS went from US$0.27 to US$0.96 in just one year. Even though that growth rate may not be repeated, that looks like a breakout improvement. Could this be a sign that the business has reached an inflection point?
Top-line growth is a great indicator that growth is sustainable, and combined with a high earnings before interest and taxation (EBIT) margin, it's a great way for a company to maintain a competitive advantage in the market. EBIT margins for Option Care Health remained fairly unchanged over the last year, however the company should be pleased to report its revenue growth for the period of 16% to US$3.7b. That's encouraging news for the company!
The chart below shows how the company's bottom and top lines have progressed over time. For finer detail, click on the image.
NasdaqGS:OPCH Earnings and Revenue History September 22nd 2022Of course the knack is to find stocks that have their best days in the future, not in the past. You could base your opinion on past performance, of course, but you may also want to check this interactive graph of professional analyst EPS forecasts for Option Care Health.
Are Option Care Health Insiders Aligned With All Shareholders?
Owing to the size of Option Care Health, we wouldn't expect insiders to hold a significant proportion of the company. But thanks to their investment in the company, it's pleasing to see that there are still incentives to align their actions with the shareholders. Indeed, they hold US$20m worth of its stock. That shows significant buy-in, and may indicate conviction in the business strategy. While their ownership only accounts for 0.4%, this is still a considerable amount at stake to encourage the business to maintain a strategy that will deliver value to shareholders.
While it's always good to see some strong conviction in the company from insiders through heavy investment, it's also important for shareholders to ask if management compensation policies are reasonable. Well, based on the CEO pay, you'd argue that they are indeed. Our analysis has discovered that the median total compensation for the CEOs of companies like Option Care Health with market caps between US$4.0b and US$12b is about US$8.4m.
The Option Care Health CEO received US$7.4m in compensation for the year ending December 2021. That is actually below the median for CEO's of similarly sized companies. While the level of CEO compensation shouldn't be the biggest factor in how the company is viewed, modest remuneration is a positive, because it suggests that the board keeps shareholder interests in mind. It can also be a sign of a culture of integrity, in a broader sense.
Does Option Care Health Deserve A Spot On Your Watchlist?
Option Care Health's earnings have taken off in quite an impressive fashion. The cherry on top is that insiders own a bucket-load of shares, and the CEO pay seems really quite reasonable. The sharp increase in earnings could signal good business momentum. Option Care Health is certainly doing some things right and is well worth investigating. Even so, be aware that Option Care Health is showing 1 warning sign in our investment analysis , you should know about...
There's always the possibility of doing well buying stocks that are not growing earnings and do not have insiders buying shares. But for those who consider these important metrics, we encourage you to check out companies that do have those features. You can access a free list of them here.
Please note the insider transactions discussed in this article refer to reportable transactions in the relevant jurisdiction.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
对于初学者来说,收购一家向投资者讲述一个好故事的公司似乎是一个好主意(也是一个令人兴奋的前景),即使它目前没有收入和利润的记录。但现实是,当一家公司每年亏损时,在足够长的时间内,投资者通常会承担他们的损失份额。亏损的公司可能会像海绵一样吸收资本,因此投资者应该谨慎,不要把钱一笔接一笔地往上扔。
尽管处于科技股蓝天投资的时代,许多投资者仍采取更传统的策略;购买盈利的公司的股票,如Option Care Health(纳斯达克:OPCH)虽然利润不是投资时应该考虑的唯一指标,但值得表彰能够持续产生利润的企业。
查看我们对Option Care Health的最新分析
Option Care Health的利润不断提高
强劲的每股收益(EPS)业绩是一家公司实现稳健利润的指标,投资者对此看好,因此股价往往反映出每股收益的良好表现。这就是每股收益增长受到如此看好的原因。令人敬畏的是,Option Care Health的每股收益在短短一年内从0.27美元上涨到0.96美元。尽管这种增长速度可能不会重现,但这看起来像是突破性的改善。这会不会是企业已经走到拐点的信号?
营收增长是一个很好的指标,表明增长是可持续的,再加上高息税前利润(EBIT)利润率,这是一家公司在市场上保持竞争优势的绝佳方式。Option Care Health的EBIT利润率与去年基本保持不变,但该公司应该很高兴地报告其收入增长16%至37亿美元。这对公司来说是个鼓舞人心的消息!
下面的图表显示了该公司的利润和收入是如何随着时间的推移而变化的。要查看更详细的信息,请点击图片。
NasdaqGS:OPCH收益和收入历史2022年9月22日当然,诀窍是找到未来最好的股票,而不是过去的股票。当然,你可以根据过去的表现来发表你的观点,但你也可能想要查看这张专业分析师对Option Care Health的每股收益预测的互动图表。
Options Care Health内部人员是否与所有股东保持一致?
鉴于Option Care Health的规模,我们预计内部人士不会持有该公司很大比例的股份。但由于他们对公司的投资,令人高兴的是,仍有激励措施让他们的行动与股东保持一致。事实上,他们持有该公司价值2000万美元的股票。这显示出大量买入,并可能表明对商业战略的信心。虽然他们的持股只占0.4%,但这仍然是一个相当大的风险,以鼓励企业保持将为股东带来价值的战略。
虽然看到内部人士通过大量投资对公司产生强烈的信心总是好事,但对股东来说,询问管理层薪酬政策是否合理也很重要。嗯,根据CEO的薪酬,你会说他们确实是这样的。我们的分析发现,像Option Care Health这样市值在40亿美元到120亿美元之间的公司的首席执行官的总薪酬中值约为840万美元。
Option Care Health首席执行官在截至2021年12月的一年中获得了740万美元的薪酬。这实际上低于类似规模公司CEO的中位数。虽然CEO的薪酬水平不应该是人们如何看待公司的最大因素,但适度的薪酬是一个积极的因素,因为它表明董事会考虑到了股东的利益。在更广泛的意义上,它也可以是一种诚信文化的标志。
Option Care Health值得在你的观察名单上占有一席之地吗?
Option Care Health的收入以相当令人印象深刻的方式增长。最重要的是,内部人士持有大量股票,首席执行官的薪酬似乎真的相当合理。盈利的大幅增长可能预示着良好的业务势头。Option Care Health确实做了一些正确的事情,非常值得研究。即使如此,请注意选项Care Health正在显示在我们的投资分析中出现1个警告信号,你应该知道关于……
总是有可能做得很好,购买股票不是不断增长的收入和不要有内部人士购买股票。但对于那些考虑这些重要指标的人,我们建议您查看以下公司做拥有这些功能。你可以在这里访问它们的免费列表。
请注意,本文中讨论的内幕交易指的是相关司法管辖区内的应报告交易。
对这篇文章有什么反馈吗?担心内容吗? 保持联系直接与我们联系。或者,也可以给编辑组发电子邮件,地址是implywallst.com。
本文由Simply Wall St.撰写,具有概括性。我们仅使用不偏不倚的方法提供基于历史数据和分析师预测的评论,我们的文章并不打算作为财务建议。它不构成买卖任何股票的建议,也没有考虑你的目标或你的财务状况。我们的目标是为您带来由基本面数据驱动的长期重点分析。请注意,我们的分析可能不会将最新的对价格敏感的公司公告或定性材料考虑在内。Simply Wall St.对上述任何一只股票都没有持仓。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧